Search Results (2,878)

Chronic lower-extremity wounds in patients undergoing exoskeleton-assisted rehabilitation require materials that can both protect tissue and enable real-time physiological monitoring. Conventional dressings lack dynamic sensing capability, while current conductive hydrogels often compromise either adhesion or electronic performance. Here, we present a biointegrated hydrogel (CPSD) composed of carboxymethyl chitosan (CMCS) and poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) forming the conductive backbone, integrated with dopamine-functionalized sodium alginate (SD); the network is assembled via electrostatic complexation and carbodiimide (EDC/NHS)-mediated covalent crosslinking. The resulting hydrogel exhibits a dense, tissue-conformal porous network with tunable swelling, stable mechanical integrity, and high photothermal conversion efficiency. In vitro assays confirmed potent antioxidant activity, strong antibacterial performance (>90% under near-infrared), and excellent cytocompatibility and hemocompatibility. CPSD shows bulk conductivity ~1.6 S·m⁻¹, compressive modulus ~15 kPa, lap-shear adhesion on porcine skin ~9.5 kPa, and WVTR ~75 g·m⁻²·h⁻¹, supporting stable biointerfaces for motion/sEMG sensing. Integrated into a lower-limb exoskeleton, CPSD hydrogels adhered securely during motion and reliably captured electromyographic and strain signals, enabling movement-intent detection. These results highlight CPSD hydrogel as a multifunctional interface material for next-generation closed-loop rehabilitation systems and mobile health monitoring. Full article

Restoring blood flow is crucial for treating refractory ulcers. Despite advancements in various biomaterials, none incorporating pre-formed blood vessels have been commercialized. To address this, we developed a pre-vascularized three-dimensional (3D) skin substitute (PV-3D skin) designed to enhance healing when treating refractory ulcers. This study aimed to evaluate the therapeutic role of PV-3D skin transplantation in refractory ulcer models, induced by applying mitomycin C to wounds in severe immunodeficient mice. The wounds were then treated with PV-3D skin, non-vascularized 3D skin, skin grafts, or wound dressings. The PV-3D skin group demonstrated healing dynamics comparable to those of the skin graft group, with similar tissue morphology and wound temperature changes. Furthermore, at day 7 post-transplantation, the PV-3D skin group demonstrated significantly higher hypoxia-inducible factor 1-alpha expression levels compared to the 3D skin group. By day 14, the PV-3D skin group exhibited a significantly larger vascular area compared to the 3D skin group. Notably, PV-3D skin treatment stimulated host-derived angiogenesis, thereby enhancing wound healing and reducing the recurrence of refractory ulcers. These results suggest that PV-3D skin transplantation offers a promising therapeutic approach for refractory ulcers, especially in terms of angiogenesis. Full article

Introduction: Chronic wounds are a growing healthcare challenge, with infections being major complications that delay healing. Biofilms are structured microbial communities encased in extracellular polymeric substances. Biofilms confer antimicrobial resistance, promote inflammation, and protect pathogens from host defenses. These mechanisms make eradication difficult with standard therapies. Methods: A focused literature review was conducted using PubMed (2010–2025) to examine the role of biofilms in chronic wounds, diabetic foot ulcers (DFUs), and burn injuries, as well as conventional and emerging treatment strategies. Studies are included if they addressed microbial composition, host–microbe interactions, or therapeutic outcomes in clinical or translational models. Discussion: Biofilms are implicated in up to 60% of chronic wounds and more than half of burn wounds. In DFUs, both bacterial and fungal biofilms contribute to chronicity and impaired healing. Conventional treatments such as debridement and antiseptics reduce surface biofilm burden but rarely achieve full eradication. Emerging approaches include quorum sensing inhibitors, bacteriophage therapy, matrix-degrading enzymes, electroceutical dressings, antifungal strategies, and nanotechnology. They show promise when integrated with standard wound care. Conclusions: Biofilms are central to the pathogenesis of chronic wounds, DFUs, and burns. Integrating mechanism-based antibiofilm therapies with standard care represents a key research priority to improve healing outcomes. Full article

This study examines the biocompatibility of 11 modern wound dressings (WDs)―Syspur-derm^®, Parapran^®, Lomatuell^®H, Voskopran^®, Metalline^®, Granuflex^®, Chitopran^®, HydroTac^®transparent, Branolind^®N, Aquacel^TM adhesive foam, Aquacel^TMAg⁺―developed for the treatment of acute and chronic wounds, and their potential use as secondary WD for the hydrogel-based bioengineered skin equivalent (BSE) “Equivalent Dermal, ED”. The study was conducted to better understand the properties of these WDs that influence the healing process. The biocompatibility of WDs was evaluated in vitro based on their effects on the viability of human dermal fibroblasts (DFs). The MTT assay, lifetime analysis of DFs’ morphological state, and analysis of their actin cytoskeletal organization using a WDs’ extracts showed that effects of WD on DFs varied among WDs. It has been revealed that WDs Parapran^®, Lomatuell^®H, Voskopran^®, Metalline^® and Chitopran^® have high biocompatibility and can be effectively used for wound treatment, whereas Granuflex^®, Syspyr-derm^®, HydroTac^® transparent, Branolind^®N, Aquacel^TM adhesive foam and Aquacel^TMAg⁺ have lower biocompatibility, so they could be used for wound therapy with caution. Only Parapran^® with chlorhexidine showed high biocompatibility with the BSE “The Dermal Equivalent, ED” and can be safely used in combination with it as a secondary WD. Full article

Background: Diabetic foot ulcers (DFUs) carry high risks of infection, amputation, and mortality. We systematically reviewed randomized controlled trials (RCTs) of negative-pressure wound therapy (NPWT), including single-use systems, for clinically uninfected DFUs (with sensitivity analyses for mixed/infected cohorts). Methods: We searched PubMed and Scopus (1 January 2004–30 June 2024). Dual reviewers performed screening and extraction; risk of bias was assessed with Cochrane Risk of Bias 2 (RoB 2) and certainty of evidence with GRADE. When ≥2 trials reported comparable outcomes, we used random-effects meta-analysis. The DiaFu cohort reported in two publications was counted once across analyses. Results: Eleven RCT publications (n = 1699; 10 unique cohorts) met criteria; eight trials (n = 1456) informed the primary endpoint. Trials largely excluded severe ischemia; findings therefore apply mainly to neuropathic or mixed-etiology DFUs with adequate perfusion. NPWT increased complete healing at 12–16 weeks (risk ratio [RR] 1.46, 95% CI 1.21–1.76; I² = 48%) and shortened time to healing (mean difference –18 days, 95% CI −28 to −8). Effects were similar for conventional and single-use NPWT. Outcomes did not vary systematically within commonly used pressure ranges (approximately −80 to −125 mmHg). Only two RCTs reported direct cost data (exploratory). Moderate heterogeneity (Higgins’ I² 48–68%) reflected variation in ulcer severity, device type/settings, dressing-change frequency, and off-loading protocols. Conclusions: NPWT probably improves short-term healing of clinically uninfected DFUs compared with standard care and may reduce minor amputations, without increasing adverse events. Certainty is moderate for healing and low for most secondary outcomes. Benefits appear consistent across device classes and may support earlier discharge and community-based care. Evidence gaps include ischemia-dominated ulcers, long-term outcomes (recurrence and limb preservation), adherence mechanisms, and contemporary cost-effectiveness. Full article

This study investigated the impacts of dietary thymol–carvacrol cocrystal (CEO) supplementation on broiler production performance, antioxidant status, intestinal health, and cecal microbiota. Eight hundred one-day-old chicks were randomly divided into four groups, receiving basal diets supplemented with 0, 40, 60, or 80 mg/kg CEO. The results showed that CEO addition increased average daily gain, superoxide dismutase activity in the serum, liver, and jejunum, jejunal villus height/crypt depth ratio, cecal butyric acid concentration, and Lactobacillus abundance, while reducing serum alanine transaminase activity and malondialdehyde content in the serum, liver, and jejunum. Furthermore, 60 mg/kg CEO enhanced the final body weight, dressing percentage, serum total protein and glucose levels, and jejunal trypsin and amylase activities, while lowering the feed-to-gain ratio and serum cholesterol, urea nitrogen, and aspartate transaminase concentrations; it also increased the activities of superoxide dismutase, catalase, and glutathione and mRNA expressions of related genes in the liver and jejunum. It also increased cecal concentrations of acetic acid and isovalerate acid, while decreasing serum diamine oxidase and D-lactate concentrations, as well as malondialdehyde concentrations in the serum, liver, and jejunum. Therefore, dietary CEO supplementation improved the production performance, antioxidant status, and liver and gut health and function in broilers, with 60 mg/kg CEO demonstrating the most pronounced effects. Full article

Skin scarring, including hypertrophic scars and keloids, often results from dysregulated collagen deposition during wound healing. Tropocollagen (TC), the soluble triple-helical precursor of collagen fibers, serves as the fundamental structural unit of the extracellular matrix (ECM) and plays a pivotal role in tissue repair. This review summarizes current knowledge on collagen and TC in wound healing, scar management, and regenerative dermatology. TC self-assembles into fibrils, providing structural support, while interacting with fibroblasts and growth factors such as transforming growth factor beta (TGF-β) and vascular endothelial growth factor (VEGF) to regulate ECM remodeling, angiogenesis, and tissue regeneration. Various collagen preparations, including hydrolyzed collagen, gelatin, and native fibrillar forms, differ in molecular structure, bioavailability, and therapeutic applications. Emerging strategies, including collagen- and TC-based hydrogels, nanomaterial composites, and smart wound dressings, enhance stability, targeted delivery, and clinical efficacy. Despite promising preclinical and early clinical data, standardized preparations and robust randomized trials are needed to validate TC’s therapeutic potential and optimize its application in scar prevention and wound repair. Full article

This study explored how top-dressed biogas slurry at winter wheat’s (Triticum aestivum L.) jointing stage (JS) and grain-filling period (GP) affects soil enzyme–microbe interactions, aiming to address nutrient supply–crop demand mismatches. A field experiment with five treatments (water [CK], chemical fertilizer [CF], and three biogas slurry topdressing regimes [S1–S3]) was conducted. Soil samples (0–20 cm) were collected at JS, flowering stage (FS), GP, and reaping period (RP) to analyze soil properties (total nitrogen [TN], available phosphorus [AP], available potassium [AK], soil organic matter [SOM], ammonium nitrogen [AN], pH), enzyme activities (urease [UE], neutral phosphatase [NP], sucrase [SC], catalase [CAT]), and microbial community abundance (via Illumina NovaSeq sequencing). Results showed biogas slurry altered enzyme activities, microbial structure (e.g., Actinomycetota, Ascomycota), and their interactions by regulating soil properties. JS application boosted Pseudomonadota and UE activity, GP application increased Ascomycota and CAT activity, and S3 had the most complex enzyme–microbe network, enhancing nutrient cycling. The analysis indicated that UE activity was strongly and positively correlated with several bacterial phyla (e.g., Planctomycetota, Verrucomicrobiota) (p < 0.01) and fungal phyla (e.g., Ascomycota) (p < 0.01). Full article

Background/Objectives: Skin wounds interrupt the natural anatomy and function of the skin. The body passes through four physiological phases to repair wounds after injury. Since the fibers are more closely related to the extracellular matrix structure, they can be used as scaffolds to accelerate wound closure. Shikonin is a botanical herbal remedy used as an anti-inflammatory agent and for its wound-healing characteristics. Cresols are known for their bactericidal and fungicidal properties, which promote their utilization as a disinfectant in soap. Therefore, this study aimed to formulate shikonin and cresol-loaded nanofibers for a dual wound-healing and antibacterial wound dressing in vitro. Methods: This study demonstrated the effectiveness of the drug-loaded nanofibers against diverse Gram-positive and Gram-negative bacteria using the minimum inhibitory concentration (MIC) and zone of inhibition assays. Results: Scanning electron microscopy images showed successful formulation of shikonin/cresol fibers with an average diameter of 772 ± 152 nm. The encapsulation efficiency and drug loading for the dual drug-loaded fibers were 44 ± 1% and 25 ± 1 µg/mg, respectively, for shikonin, and 38 ± 1% and 21 ± 0.5 µg/mg, respectively, for cresol, with a full release of both drugs achieved after 180 min. The combination of both compounds exhibited a safe concentration of ≤6 µg/mL, with cell viability of >50% in human dermal fibroblasts (HFF-1) after 24 h. The MIC results indicated that the combination was efficient as an antibacterial agent against Gram-positive bacteria at a safe concentration. The shikonin/cresol-loaded fibrous system showed an inhibition zone close to that of the control drugs, suggesting that the drugs have retained their antibacterial activity after electrospinning. Conclusions: This dual drug-loaded fiber system showed a high potential as an antibacterial wound dressing for skin infection injuries. However, in vivo studies are required to assess the safety and efficacy in an animal model of the dual drug-loaded fiber system. Full article

Background: Personalized medicine in breast cancer surgery aims to tailor therapeutic strategies not only to tumor biology but also to patient-specific risk factors and surgical outcomes. The Alexis^® retractor, originally designed for abdominal and pelvic surgery, may represent an innovative tool to optimize axillary surgical procedures in selected patients. Its atraumatic design and protective sheath provide enhanced visibility, minimized tissue trauma, and a potentially lower risk of postoperative complications, thus contributing to individualized surgical care. Methods: We conducted a retrospective, single-center study at Fondazione Policlinico Universitario Agostino Gemelli IRCCS between January 2024 and April 2025. Patients undergoing breast-conserving surgery or mastectomy with axillary access were included. The Alexis^® retractor was used for axillary tissue retraction in procedures such as sentinel lymph node biopsy and axillary dissection. Outcomes were assessed at 7, 14, and 30 days postoperatively, with particular focus on complication rates and surgical efficiency. Results: Thirty-seven patients (38 procedures) were analyzed. Seromas occurred in four patients (10.8%) and were managed with ultrasound-guided aspiration. Wound dehiscence occurred in two patients (5.4%) and was treated with advanced dressings. No infections, hemorrhages, or flap necrosis were observed. No systemic complications occurred. Conclusions: The preliminary results suggest that the Alexis^® retractor may support a more personalized approach to axillary surgery in breast cancer, by reducing early postoperative complications and improving surgical ergonomics. Its atraumatic design and protective sheath may help tailor surgical management to individual patient risk profiles, minimizing tissue damage and infection risk while enhancing intraoperative visibility and efficiency. Further prospective, controlled studies with larger cohorts are needed to confirm its role in precision breast surgery and to define which patient subgroups may benefit the most. Full article

The development of advanced wound dressings that integrate favorable physico-mechanical properties with the ability to support physiological healing processes remains a critical challenge in biomaterials science. An ideal dressing should modulate the wound microenvironment, prevent infection, maintain hydration, and possess adequate strength and elasticity. This study aimed to fabricate and characterize electrospun chitosan (CS)-based 3D scaffolds dual-reinforced with halloysite nanotubes (HNTs) and cerium oxide nanoparticles (CeONPs) to enhance material properties and biological performance. HNTs were incorporated to improve electrospinnability and provide mechanical reinforcement, while CeONPs were added for their redox-modulating and anti-inflammatory activities. Composite mats were fabricated via non-capillary electrospinning. The individual and synergistic effects of HNTs and CeONPs were systematically evaluated using physico-chemical methods (SEM, EDX, WAXS, TGA, mechanical testing) and biological assays (in vitro cytocompatibility with mesenchymal stem cells, in vivo biocompatibility, and wound healing efficacy in a rat model). Scaffolds containing only HNTs exhibited defect-free nanofibers with an average diameter of 151 nm, whereas the dual-filler (CS-PEO-HNT-CeONP) composites showed less uniform fibers with a rough surface and a larger average diameter of 233 nm. The dual-filler system demonstrated significantly enhanced mechanical properties, with a Young’s modulus nearly double that of pure CS mats (881 MPa vs. 455 MPa), attributed to strong interfacial interactions. In vivo, the CS-PEO-HNT-CeONP scaffolds degraded more slowly, promoted earlier formation of a connective tissue capsule, and elicited a reduced inflammatory response compared to single-filler systems. Although epithelialization was temporarily delayed, the dual-filler composite ultimately facilitated superior tissue regeneration, characterized by a more organized, native-like collagen architecture. The synergistic combination of HNTs and CeONPs within a CS matrix yields a highly promising scaffold for wound management, offering a unique blend of tailored biodegradability, enhanced mechanical strength, and the ability to guide healing towards a regenerative rather than a fibrotic outcome, particularly for burns and traumatic injuries. Full article

This study offers an integrated synthesis of polymeric materials in biomedical engineering, revealing four major and interlinked research domains: tissue engineering and regenerative medicine, drug delivery and nanomedicine, wound healing and antimicrobial applications, and advanced fabrication through 3D/4D printing and bioprinting. Across these areas, hydrogels, biodegradable composites, and stimuli-responsive polymers emerge as the most influential material classes. The analysis highlights substantial progress in extracellular matrix–mimetic scaffolds, smart drug delivery systems with controlled release, multifunctional wound dressings integrating antimicrobial and healing functions, and patient-specific constructs produced via additive manufacturing. Despite these advances, recurring challenges persist in long-term biocompatibility and safety, scalable and reproducible fabrication, and regulatory standardisation. The results point toward a convergence of bioactivity, manufacturability, and clinical translation, with hybrid natural–synthetic systems and personalised polymeric designs defining the next phase of biomedical polymer innovation. Full article

Hydrogels are three-dimensional polymeric networks capable of retaining large amounts of water. Polyvinyl alcohol (PVA)-based hydrogels exhibit autonomous self-healing through reversible physical interactions within the hydrogel matrix, including hydrogen bonding, crystallite formation, and dynamic crosslinking. However, their long self-healing times and low strength limit practical application. Herein, we propose an effective strategy to simultaneously achieve excellent self-repairing and high mechanical strength. The tensile strength of uncut PVA hydrogel was 1.21 MPa; after cutting and rejoining for 12 h at room temperature (RT), it recovered 94% of the original uncut strength. To accelerate self-healing, hydrogels were treated at 40, 50, and 60 °C for 20, 40, and 60 min. Under optimal conditions (60 °C for 60 min), 96% recovery was achieved. Mechanical properties were further improved by silica (Si) nanoparticles of various sizes (~12, ~85, and ~200 nm). Si-loaded hydrogels, particularly ~12 nm, demonstrated increased mechanical properties, reaching a tensile strength of 1.45 MPa and a self-healing recovery of 95% of the uncut hydrogel strength. Ultra-small (~12 nm) Si nanoparticles enhanced the overall mechanical properties by acting as an efficient nucleating agent and did not hinder the existing self-healing mechanism. The developed strategy will pave the way for novel techniques in hydrogel research and will advance applications such as soft robotics and wound dressing. Full article

Chronic wounds (such as diabetic foot ulcers and pressure ulcers) affect millions of patients worldwide. These non-healing wounds pose major clinical challenges due to persistent inflammation, high infection risk, and impaired tissue regeneration, and incur a substantial healthcare burden, with global wound care costs reaching tens of billions of dollars annually. This unmet need has spurred the development of intelligent wound dressings—advanced bioengineered systems that go beyond conventional passive wound coverings by actively monitoring the wound microenvironment and responding dynamically to promote tissue repair. This review comprehensively examines a broad range of smart wound dressing technologies, including pH-sensitive, temperature-responsive, moisture-responsive, pressure-sensing, electroactive, biosensor-integrated, shape-memory, and controlled drug-releasing systems. We also discuss critical challenges in translating these innovations to clinical practice, such as ensuring biocompatibility and long-term stability in the harsh wound environment, manufacturing scalability and cost-effectiveness, patient comfort and adherence, and navigating regulatory hurdles. By emphasizing recent bioengineering advances and clinical potential, we underscore that intelligent wound dressings represent a paradigm shift in chronic wound management—enabling continuous, personalized therapy with the potential to significantly improve healing outcomes, reduce complications, and improve patient quality of life. Full article

Conventional polishing of glass substrates often results in surface scratches caused by passivated abrasive particles, leading to defects and reduced yield. To overcome this limitation, an iron-bonded wheel with free abrasive grains was proposed in ELID (Electrolytic In-process Dressing) grinding. The polishing mechanisms were investigated using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), and micro-indentation. Polishing efficiency was assessed via mass loss measurements, surface quality was characterized by atomic force microscopy (AFM), and optical transmittance was evaluated using a transmittance meter. Results indicate that the proposed wheel does not contain fixed abrasive particles but generates α-Fe₂O₃ particles during polishing, effectively preventing surface scratches and achieving superior surface quality. The polishing efficiency ranged from 0.02 to 1.6 μm/min, with a resulting surface roughness of 2.1 nm. Furthermore, the glass substrates exhibited higher transmittance compared to those polished using conventional methods, contributing to improved display performance and brightness. This polishing technology demonstrates significant potential for applications in the display industry. Full article